Induction of TGF-β1 and TGF-β1-dependent predominant Th17 differentiation by group A streptococcal infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 13, 2010, Pages 5937-5942

  Wang, Beinan ^a   Dileepan, Thamotharampillai ^a   Briscoe, Sarah ^a   Hyland, Kendra A ^b   Kang, Johnthomas ^c   Khoruts, Alexander ^c   Cleary, P Patrick ^a  

^a Department of Microbiology ^*  (United States)

^b Discovery Genomics Inc   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

IL 17; Nasal associated lymphoid tissue; Streptococcus pyogenes

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 6; LUCIFERASE; TRANSFORMING GROWTH FACTOR BETA1; CYTOKINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROTECTION; CELL SUSPENSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GROUP A STREPTOCOCCAL INFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; LYMPHOID TISSUE; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STAINING; T LYMPHOCYTE; TH17 CELL; TONSIL; TONSILLITIS; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELLULAR IMMUNITY; GENETICS; HELPER CELL; IMMUNOLOGY; LISTERIA MONOCYTOGENES; LISTERIOSIS; METABOLISM; MOUSE MUTANT; NOSE CAVITY; PATHOGENICITY; PATHOLOGY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

BACTERIA (MICROORGANISMS); MUS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-17; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NASAL CAVITY; SIGNAL TRANSDUCTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TONSILLITIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77950538944     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0904831107     Document Type: Article

References (42)

1. Brook I (1994) Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis. J Fam Pract 38:175-179. (Pubitemid 24058778)
2. Paradise JL, et al. (2002) Tonsillectomy and adenotonsillectomy for recurrent throat infection in moderately affected children. Pediatrics 110:7-15.
3. Cunningham MW (2008) Pathogenesis of group A streptococcal infections and their sequelae. Adv Exp Med Biol 609:29-42.
4. Wang B, Li S, Southern PJ, Cleary PP (2006) Streptococcal modulation of cellular invasion via TGF-beta1 signaling. Proc Natl Acad Sci USA 103:2380-2385. (Pubitemid 43271678)
5. Harrington LE, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132.
6. Bettelli E, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
7. Stockinger B, Veldhoen M, Martin B (2007) Th17 T cells: Linking innate and adaptive immunity. Semin Immunol 19:353-361.
8. Li MO, Flavell RA (2008) TGF-beta: A master of all T cell trades. Cell 134:392-404.
9. Park HS, Francis KP, Yu J, Cleary PP (2003) Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol 171:2532-2537. (Pubitemid 37025563)
10. Kumar RB, Maher DM, Herzberg MC, Southern PJ (2006) Expression of HIV receptors, alternate receptors and co-receptors on tonsillar epithelium: Implications for HIV binding and primary oral infection. Virol J 3:25-37.
11. Osterlund A, Popa R, Nikkilä T, Scheynius A, Engstrand L (1997) Intracellular reservoir of Streptococcus pyogenes in vivo: A possible explanation for recurrent pharyngotonsillitis. Laryngoscope 107:640-647. (Pubitemid 27200638)
12. Gerber MA, et al. (1999) Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 104:911-917.
13. Yang L, et al. (2008) IL-21 and TGF-beta are required for differentiation of human T (H)17 cells. Nature 454:350-352.
14. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189. (Pubitemid 43214587)
15. Kattah MG, Wong MT, Yocum MD, Utz PJ (2008) Cytokines secreted in response to Toll-like receptor ligand stimulation modulate differentiation of human Th17 cells. Arthritis Rheum 58:1619-1629.
16. Rharbaoui F, et al. (2005) Characterization of a B220+ lymphoid cell subpopulation with immune modulatory functions in nasal-associated lymphoid tissues. J Immunol 174:1317-1324.
17. Lim HW, Lee J, Hillsamer P, Kim CH (2008) Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J Immunol 180:122-129.
18. Pamer EG (2004) Immune responses to Listeria monocytogenes. Nat Rev Immunol 4: 812-823.
19. Hyland KA, et al. (2009) The early interferon response of nasal-associated lymphoid tissue to Streptococcus pyogenes infection. FEMS Immunol Med Microbiol 55:422-431.
20. Aujla SJ, et al. (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14:275-281.
21. Nakae S, et al. (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387. (Pubitemid 35279557)
22. Li MO, Wan YY, Flavell RA (2007) T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26:579-591.
23. Li H, Nooh MM, Kotb M, Re F (2008) Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production. J Leukocyte Biol 83:409-418.
24. Park HS, et al. (2004) Primary induction of CD4 T cell responses in nasal associated lymphoid tissue during group A streptococcal infection. Eur J Immunol 34:2843-2853.
25. Gutcher I, Becher B (2007) APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 117:1119-1127. (Pubitemid 46718396)
26. Korn T, et al. (2008) IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc Natl Acad Sci USA 105: 18460-18465.
27. Curtis MM, Way SS (2009) Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126:177-185.
28. Kolb-Mäurer A, Kurzai O, Goebel W, Frosch M (2003) The role of human dendritic cells in meningococcal and listerial meningitis. Int J Med Microbiol 293:241-249. (Pubitemid 37040018)
29. Kwinn LA, Nizet V (2007) How group A Streptococcus circumvents host phagocyte defenses. Future Microbiol 2:75-84.
30. Bettelli E, Korn T, Oukka M, Kuchroo VK (2008) Induction and effector functions of T (H)17 cells. Nature 453:1051-1057.
31. Lu YJ, et al. (2008) Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4:e1000159.
32. Bisno AL, Rubin FA, Cleary PP, Dale JB; National Institute of Allergy and Infectious Diseases (2005) Prospects for a group A streptococcal vaccine: Rationale, feasibility, and obstacles - Report of a National Institute of Allergy and Infectious Diseases workshop. Clin Infect Dis 41:1150-1156.
33. Ishigame H, et al. (2009) Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30: 108-119.
34. Aujla SJ, Kolls JK (2009) IL-22: A critical mediator in mucosal host defense. J Mol Med 87:451-454.
35. Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139-145.
36. Mezzano S, Burgos ME, Olavarría F, Caorsi I (1997) Immunohistochemical localization of IL-8 and TGF-beta in streptococcal glomerulonephritis. J Am Soc Nephrol 8: 234-241. (Pubitemid 127455878)
37. Nockowski P, Szepietowski JC, Ziarkiewicz M, Baran E (2004) Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris. Acta Dermatovenerol Croat 12:2-6. (Pubitemid 38524290)
38. Kim L, et al. (2008) Overexpression of transforming growth factor-beta 1 in the valvular fibrosis of chronic rheumatic heart disease. J Korean Med Sci 23:41-48.
39. Cunningham MW (2004) T cell mimicry in inflammatory heart disease. Mol Immunol 40:1121-1127. (Pubitemid 38221194)
40. Wang B, Yurecko RS, Dedhar S, Cleary PP (2006) Integrin-linked kinase is an essential link between integrins and uptake of bacterial pathogens by epithelial cells. Cell Microbiol 8:257-266. (Pubitemid 43356048)
41. Pape KA, Khoruts A, Mondino A, Jenkins MK (1997) Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells. J Immunol 159:591-598. (Pubitemid 127484207)
42. Winstead CJ, Fraser JM, Khoruts A (2008) Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells. J Immunol 180:7305-7317.